Afficher la couverture 'International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. | Travis, William, D.' en grand format
/5

0 avis

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Archive ouverte

Travis, William, D. | Brambilla, Elisabeth | Noguchi, Masayuki | Nicholson, Andrew, G. | Geisinger, Kim, R. | Yatabe, Yasushi | Beer, David, G. | Powell, Charles, A. | Riely, Gregory, J. | van Schil, Paul, E. | Garg, Kavita | Austin, John, H. M. | Asamura, Hisao | Rusch, Valerie, W. | Hirsch, Fred, R. | Scagliotti, Giorgio, V. | Mitsudomi, Tetsuya | Huber, Rudolf, M. | Ishikawa, Yuichi | Jett, James, R. | Sanchez-Cespedes, Montserrat | Sculier, Jean-Paul | Takahashi, Takashi | Tsuboi, Masahiro | Vansteenkiste, Johan | Wistuba, Ignacio | Yang, Pan-Chyr | Aberle, Denise | Brambilla, Christian | Flieder, Douglas, B. | Franklin, Wilbur | Gazdar, Adi | Gould, Michael | Hasleton, Philip | Henderson, Douglas | Johnson, Bruce | Johnson, David | Kerr, Keith | Kuriyama, Keiko | Lee, Jin Soo | Miller, Vincent, A. | Petersen, Iver | Roggli, Victor | Rosell, Rafael | Saijo, Nagahiro | Thunnissen, Erik | Tsao, Ming | Yankelewitz, David

Edité par CCSD ; Lippincott, Williams & Wilkins -

International audience. This new classification strategy is based on a multidisciplinary approach to diagnosis of lung adenocarcinoma that incorporates clinical, molecular, radiologic, and surgical issues, but it is primarily based on histology. This classification is intended to support clinical practice, and research investigation and clinical trials. As EGFR mutation is a validated predictive marker for response and progression-free survival with EGFR tyrosine kinase inhibitors in advanced lung adenocarcinoma, we recommend that patients with advanced adenocarcinomas be tested for EGFR mutation. This has implications for strategic management of tissue, particularly for small biopsies and cytology samples, to maximize high-quality tissue available for molecular studies. Potential impact for tumor, node, and metastasis staging include adjustment of the size T factor according to only the invasive component (1) pathologically in invasive tumors with lepidic areas or (2) radiologically by measuring the solid component of part-solid nodules.

Suggestions

Du même auteur

Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer.

Archive ouverte | Travis, William, D. | CCSD

International audience. OBJECTIVE: To define the anatomic extent of visceral pleural invasion (VPI) and to assess whether elastic stains are useful to determine VPI in lung cancer. The elastic layer of the visceral ...

Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007.

Archive ouverte | Lim, Eric | CCSD

International audience. The International Association for the Study of Lung Cancer, (IASLC) International Congress on Advances in Pulmonary Neuroendocrine Tumors was a two-day meeting held at the Royal Brompton Hosp...

The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer.

Archive ouverte | Travis, William, D. | CCSD

International audience. OBJECTIVE: In the 2003 Supplement for tumor, node, metastasis (TNM) Staging classification it states that TNM staging "applies to all types of carcinoma including small cell carcinoma; howeve...

Chargement des enrichissements...